May 2022 - QualityStocks

TuesdayMay 31, 2022 3:00 pm

DGE’s 2nd KOL Engagement Forum Designed To Foster Partnership Ties With KOLs

Life science companies and professionals are invited to attend Dynamic Global Events’ (“DGE”) 2nd KOL Engagement Forum, livestreaming June 1-2, 2022. A pioneer in organizing networking events, Dynamic Global Events focuses on delivering high-quality data and networking avenues to the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries. The forum is designed for medical and life science professionals to create strong networking ties and cultivate strong long-term relationships with the most influential thought leaders in the industry. In these uncertain times when there is growing distrust for institutions, these respected partnerships will foster confidence and lend credibility to the products. KOLs…

TuesdayMay 31, 2022 2:31 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Inks Acquisition Agreement, Subsidiary Explores Expanding Portfolio

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company, has signed a material definitive agreement to acquire GeoTraq Inc. from NASDAQ-traded JanOne Inc. (NASDAQ: JAN). According to the announcement, GeoTraq develops and manufactures self-contained and ultra-small Mobile Internet of Things (“IoT”) modules that can be used for asset tracking and location-based services, as well as sensor modules for remote monitoring. GeoTraq Mobile IoT modules are small, offer a long battery life, consume low power and provide global LPWAN connectivity. Because the modules work right out of the box, users eliminate the hassle and cost of designing and building a printed circuit…

TuesdayMay 31, 2022 2:12 pm

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces Completion of Annual Filings

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has reported that, further to its news release dated May 16, 2022, the company has filed its annual financial statements, management’s discussion and analysis, and related certifications for the year ended Dec. 31, 2021, (collectively, the “annual filings”). Delic expects that the management cease trade order (the “MCTO”), which was issued on May 3, 2022, will be revoked in the coming days. While the MCTO remains in effect, the general investing public will continue to be able to trade Delic’s securities.…

TuesdayMay 31, 2022 1:24 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Exceptional Test Performance of Solid-State Polymer Battery

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced results of its solid-state polymer battery testing with the Battery Innovation Center (“BIC”) in Indiana. According to the update, BIC’s testing results show the solid-state polymer cell, rated at 300 Ah and 3.7 volts, tested in at 343.28 Ah at 4.2 volts, exceeding expectation and in line with test tolerance from previous EV Grid test results. Test data collected from both BIC and EV Grid demonstrate an impressive outcome and future for solid-state batteries. It is expected that with this technology, when scaled to the vehicle pack level,…

TuesdayMay 31, 2022 12:38 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Launch of JustCBD Products on Amazon.co.uk

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its wholly-owned subsidiary JustCBD will be launching its line of Novel Foods-registered CBD products on Amazon.co.uk. Since its entry into the now £700 million CBD market in October 2021, Amazon U.K. has expanded the initial pilot-only program to include vendors who have demonstrated compliance with U.K. CBD Novel Food regulations. Producers awarded U.K. Novel Food authorization must prove the product is safe for consumption and labeled correctly. “With health and wellness playing an increasingly important role in customers’ lives, we are…

TuesdayMay 31, 2022 12:00 pm

CWCBExpo, the Premier B2B Cannabis, and Hemp Expo and Conference to Foster Lively Discussion on Industry Opportunities and Challenges Among Seasoned Professionals and Newcomers Alike

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held between June 2-4, 2022, at the Javits Convention Center, Hall 3A, in New York City. Industry heavyweights, the foremost innovators, and pioneering thought leaders will take the stage to discuss emerging trends in cannabis, hemp, and allied sectors. The expo will provide a high-quality business-focused attendee base located in the premier East Coast US cannabis and hemp market. The three-day event will feature an Inside the Industry: Thought Leadership Series in an interactive “Talk Show” format. Co-hosts will include Carl Cameron, veteran journalist and former FOX News reporter; Faye…

TuesdayMay 31, 2022 11:15 am

Silo Pharma Inc. (SILO) Focuses on Psilocybin’s Anti-Inflammatory Properties

On May 19, 2022, Silo Pharma (OTCQB: SILO) announced that The Translational Psychedelic Research (“TrPR”) Program at UCSF (University of California San Francisco) had “successfully dosed [with psilocybin] patients suffering from Parkinson’s disease.” TrPR connects researchers and medical professionals studying how psychedelics, including psilocybin, ketamine, etc., affect brain functions and other organ systems. Silo Pharma focuses on palliative uses of psychedelics for “PTSD, Parkinson’s, and other rare neurological disorders.” In teaming up with TrPR. Silo is exploring psilocybin’s anti-inflammatory possibilities in patients exhibiting signs of Parkinson’s Disease. Psilocybin’s journey from magic mushrooms to potential life savers has been a long,…

TuesdayMay 31, 2022 11:14 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Completes Major Step in Advancement of CYB003 for the Treatment of Major Depressive Disorder

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced the submission of an Investigational New Drug (“IND”) application to the U.S. Food and Drug Administration (“FDA”). According to the update, the IND is for Cybin’s phase 1/2a first-in-human clinical trial evaluating CYB003, a proprietary deuterated psilocybin analog, for the treatment of major depressive disorder (“MDD”). “Following the successful completion of our IND-enabling work just last month, we are very excited to have reached this major milestone toward advancing CYB003 into clinical development so quickly. Based on preclinical studies, our proprietary psilocybin analog…

TuesdayMay 31, 2022 11:05 am

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR) Releases Q1 2022 Financial Report

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a propriety SaaS technology company delivering mobile-first live-dealer technology to online gaming operators globally, is reporting its first quarter 2022 financial numbers; the report is for the quarter ended March 31, 2022. Highlights of the report include company revenues of $140,877, which came from Playgon’s Live Dealer platform. The company noted that it saw increased player betting throughout the quarter, a strong indicator for future revenue growth. In addition, Playgon observed an increase in player win percentage resulting in reduced house margins. The company also reported loss for the quarter of $3,899,555,…

Site Search

Company Search

Month: May 2022